Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(261)

44. Revolutionizing the drug discovery marketplace, Kevin Lustig, Founder and CEO, Scientist.com

44. Revolutionizing the drug discovery marketplace, Kevin Lustig, Founder and CEO, Scientist.com

Kevin is a scientist-entrepreneur with 30 years of research experience in academia and pharma. He co-founded Scientist.com in 2007. In 2001, he co-founded Kalypsys, a small pharmaceutical company. He ...

3 Feb 202123min

43. From health economics to COVID19 treatment, Jonathan Javitt, Co-Founder and CEO, NeuroRx Pharma

43. From health economics to COVID19 treatment, Jonathan Javitt, Co-Founder and CEO, NeuroRx Pharma

Dr. Javitt has played leadership roles in seven successful healthcare IT and biopharma startups with public exits. He has additionally led drug-development engagements for Merck, Allergan, Pharmacia, ...

27 Jan 202133min

42. Combating COVID19, Mei Mei Hu, Co-Founder and CEO, and Peter Diamandis, Co-Founder, COVAXX

42. Combating COVID19, Mei Mei Hu, Co-Founder and CEO, and Peter Diamandis, Co-Founder, COVAXX

Mei Mei Hu: Mei Mei is also CEO of United Neuroscience and a member of the executive committee of United Biomedical, Inc. She oversaw the launch of one of the first endobody vaccines in the world and ...

20 Jan 202124min

41. Tackling the mental health pandemic, Shawn Singh, CEO, VistaGen Therapeutics

41. Tackling the mental health pandemic, Shawn Singh, CEO, VistaGen Therapeutics

Shawn Singh has served as our Chief Executive Officer since August 2009; he joined our Board of Directors in 2000. Mr. Singh has nearly 30 years of experience working with private and public biotechno...

13 Jan 202119min

40. Approaches to immunology, inflammation, and oncology, Dr. Luisa Salter-Cid, CSO, Gossamer Bio

40. Approaches to immunology, inflammation, and oncology, Dr. Luisa Salter-Cid, CSO, Gossamer Bio

Dr. Salter-Cid brings to Gossamer Bio over 20 years of drug discovery experience in the biotech and pharmaceutical industries and spent the last 13 years at Bristol Myers Squibb (“BMS”) in increasing ...

6 Jan 202129min

39. Biotech2050 Season 1 Wrap Up: Co-Hosts, Alok Tayi and Rahul Chaturvedi

39. Biotech2050 Season 1 Wrap Up: Co-Hosts, Alok Tayi and Rahul Chaturvedi

Thank you for your support for Season 1! We reflect and look forward to Season 2 on this episode! Learn more about our co-hosts below! Alok Tayi is the Vice President of Life Sciences at Egnyte where...

16 Des 202010min

38. AI-driven early detection cancer screening from a blood test, Ken Chahine, CEO, Helio Health

38. AI-driven early detection cancer screening from a blood test, Ken Chahine, CEO, Helio Health

As Executive Vice President and General Manager of Ancestry.com, a 1.6 billion dollar technology company, Ken led the launch of AncestryDNA, a large-scale e-commerce genetic genealogy test with revenu...

11 Nov 202022min

37. Bringing new treatments to psychiatric orphan diseases, Ibs Mahmood, CEO, AMO Pharma

37. Bringing new treatments to psychiatric orphan diseases, Ibs Mahmood, CEO, AMO Pharma

Ibraheem Mahmood has an extensive life science and finance background that spans more than 20 years. His experience includes previous roles in Lifescience M&A and Fundraising at Nomura, Lifescience Eq...

4 Nov 202023min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
sinnsyn
jss
forskningno
liberal-halvtime
villmarksliv
rss-paradigmepodden
rekommandert
vett-og-vitenskap-med-gaute-einevoll
fjellsportpodden
aldring-og-helse-podden
rss-rekommandert
rss-inn-til-kjernen-med-sunniva-rose
tomprat-med-gunnar-tjomlid
kvinnehelsepodden
grunnstoffene
diagnose
rss-overskuddsliv
rss-bondevennen